Main menu

Infectious disease

Rapid access to results

Offering comprehensive, real-time insights into the genomics of infectious diseases — from pathogen identification and antimicrobial resistance (AMR) profiling to the assembly of high-quality genomes and variant identification — Oxford Nanopore sequencing delivers immediate access to the critical genomic epidemiology data required to effectively control infectious disease outbreaks.

Sequence in the lab or at sample source at a scale that suits your needs, with powerful portable and high-throughput Oxford Nanopore sequencing devices.

Preventing pandemics


AmPORE-TB

AmPORE-TB is a research workflow that delivers rapid characterisation of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis, species identification, and lineage identification in a single assay, directly from sputum samples.

Combining fast library preparation with on-demand nanopore sequencing and hands-off, comprehensive analysis onboard the GridION AmPORE-TB device, the AmPORE-TB workflow can take as little as six hours for same-day results.

The GridION AmPORE-TB device, installed with the AmPORE-TB data analysis software, will be distributed by bioMérieux (Q-GRD-MK1-ATB).


Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

About Oxford Nanopore

Contact us News Media resources & contacts Investor centre Careers BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Spanish flag